Familial Alzheimer&rsquo;s disease modelling using induced pluripotent stem cell technology

doi:10.4252/wjsc.v6.i2.239

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 2

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7255)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series.

Item

Count

PDF

414

WORD

358

HTML

4455

Figures (1-4)

237

Sum=5464

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

969

Download

822

Sum=1791

Apr 26, 2014 (publication date) through Nov 13, 2024

Times Cited of This Article

Times Cited (20)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Stem Cells. Apr 26, 2014; 6(2): 239-247
Published online Apr 26, 2014. doi: 10.4252/wjsc.v6.i2.239

Full Size Figure Download Figure

Figure 4 Example of how high content screening of patient-derived induced pluripotent stem cells could aid stratification of existing drug treatments and help identify genetic profiles associated with specific disease phenotypes.

Citation: Mohamet L, Miazga NJ, Ward CM. Familial Alzheimer’s disease modelling using induced pluripotent stem cell technology. World J Stem Cells 2014; 6(2): 239-247
URL: https://www.wjgnet.com/1948-0210/full/v6/i2/239.htm
DOI: https://dx.doi.org/10.4252/wjsc.v6.i2.239